![]()
|
Report Date : |
26.07.2011 |
IDENTIFICATION DETAILS
|
Name : |
BIOGENTEK BG ( |
|
|
|
|
Registered
Office : |
106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak
Puri, New Delhi – 110 058 |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as
on) : |
31.03.2010 |
|
|
|
|
Date of
Incorporation : |
13.03.1998 |
|
|
|
|
Com. Reg. No.: |
55-093006 |
|
|
|
|
Capital
Investment / Paid-up Capital : |
Rs.0.100 million |
|
|
|
|
CIN No.: [Company Identification
No.] |
U74130DL1998PTC093006 |
|
|
|
|
Legal Form : |
Private Limited Liability Company |
|
|
|
|
Line of Business
: |
Manufacturer of Sensors Transducers and Weighing Scales Measuring Tapes. |
|
|
|
|
No. of Employees
: |
Not Available |
RATING & COMMENTS
|
MIRA’s Rating : |
B (31) |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
Maximum Credit Limit : |
USD 9000 |
|
|
|
|
Status : |
Small Company |
|
|
|
|
Payment Behaviour : |
Slow but correct |
|
|
|
|
Litigation : |
Clear |
|
|
|
|
Comments : |
Subject is a relatively small company in its field. Its scale of
activities are limited. However, trade relations are reported as fair.
Business is active. Payments are reported to be slow but correct. The company can be considered for small to mediocre business dealings
at usual trade terms and conditions. |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – April 1, 2010
|
Country Name |
Previous Rating (31.12.2009) |
Current Rating (01.04.2010) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
LOCATIONS
|
Registered Office : |
106, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block,
Janak Puri, New Delhi – 110 058, India
|
|
Tel. No.: |
91-11-25573125, 25513104 |
|
Fax No.: |
91-11-25513106 |
|
E-Mail : |
|
|
Website : |
|
|
|
|
|
Branch Office : |
Located at: v
v
Chennai v
Mumbai v
Kolkata v
v
v
v
v
v
Guwahati |
DIRECTORS
As on 29.09.2010
|
Name : |
Mr. Neeraj Pandey |
|
Designation : |
Director |
|
Address : |
C-8/8005, Vasant Kunj, |
|
Date of Appointment : |
30.03.1998 |
|
DIN No.: |
01135827 |
|
|
|
|
Name : |
Mr. Sanjay Gulati |
|
Designation : |
Director |
|
Address : |
GH9/204, Pachim Vihar, |
|
Date of Appointment : |
30.03.1998 |
|
DIN No.: |
01135794 |
MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN
As on 29.09.2010
|
Names of Shareholders |
|
No. of Shares |
|
Neeraj Pandey |
|
5000 |
|
Sanjay Gulati |
|
5000 |
|
Total |
|
10000 |
As on 29.09.2010
|
Equity Share Breakup |
|
Percentage of Holding |
|
Category |
|
|
|
Directors
or relatives of directors |
|
100.00 |
BUSINESS DETAILS
|
Line of Business : |
Manufacturer of Sensors Transducers and Weighing Scales Measuring Tapes. |
|
|
|
GENERAL INFORMATION
|
No. of Employees : |
Not Available |
|||||||||
|
|
|
|||||||||
|
Bankers : |
Corporation Bank, Janakpuri, |
|||||||||
|
|
|
|||||||||
|
Facilities : |
|
|
|
|
|
Banking
Relations : |
-- |
|
|
|
|
Auditors : |
|
|
Name : |
Rajendra Singh and Company Chartered Accountants |
|
Address : |
S-3, Pankaj Central Market, IP Extension, Patparganj,
|
|
Income-tax
PAN of auditor or auditor's firm : |
AAQPS9850G |
CAPITAL STRUCTURE
As on 31.03.2010
Authorised Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
50000 |
Equity Shares |
Rs.10/- each |
Rs.0.500 million |
|
|
|
|
|
Issued, Subscribed & Paid-up Capital :
|
No. of Shares |
Type |
Value |
Amount |
|
10000 |
Equity Shares |
Rs.10/- each |
Rs.0.100 million |
|
|
|
|
|
FINANCIAL DATA
[all figures are
in Rupees Millions]
ABRIDGED BALANCE
SHEET
|
SOURCES OF FUNDS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
SHAREHOLDERS FUNDS |
|
|
|
|
|
1] Share Capital |
0.100 |
0.100 |
0.100 |
|
|
2] Share Application Money |
0.000 |
0.000 |
0.000 |
|
|
3] Reserves & Surplus |
2.222 |
1.272 |
0.896 |
|
|
4] (Accumulated Losses) |
0.000 |
0.000 |
0.000 |
|
|
NETWORTH |
2.322 |
1.372 |
0.996 |
|
|
LOAN FUNDS |
|
|
|
|
|
1] Secured Loans |
0.824 |
0.864 |
0.597 |
|
|
2] Unsecured Loans |
0.000 |
0.000 |
0.000 |
|
|
TOTAL BORROWING |
0.824 |
0.864 |
0.597 |
|
|
DEFERRED TAX LIABILITIES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3.146 |
2.236 |
1.593 |
|
|
|
|
|
|
|
|
APPLICATION OF FUNDS |
|
|
|
|
|
|
|
|
|
|
|
FIXED ASSETS [Net Block] |
1.905 |
1.889 |
1.185 |
|
|
Capital work-in-progress |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
INVESTMENT |
0.000 |
0.000 |
0.000 |
|
|
DEFERREX TAX ASSETS |
0.271 |
0.050 |
0.041 |
|
|
|
|
|
|
|
|
CURRENT ASSETS, LOANS & ADVANCES |
|
|
|
|
|
|
Inventories |
0.000
|
0.276 |
0.000 |
|
|
Sundry Debtors |
1.360
|
0.316 |
0.733 |
|
|
Cash & Bank Balances |
2.999
|
1.469 |
3.336 |
|
|
Other Current Assets |
0.000
|
0.000 |
0.000 |
|
|
Loans & Advances |
3.907
|
2.628 |
1.299 |
|
Total
Current Assets |
8.266
|
4.689 |
5.368 |
|
|
Less : CURRENT
LIABILITIES & PROVISIONS |
|
|
|
|
|
|
Sundry Creditors |
1.923
|
1.767 |
1.280 |
|
|
Other Current Liabilities |
4.073
|
1.693 |
3.050 |
|
|
Provisions |
1.300
|
0.932 |
0.671 |
|
Total
Current Liabilities |
7.296
|
4.392 |
5.001 |
|
|
Net Current Assets |
0.970
|
0.297 |
0.367 |
|
|
|
|
|
|
|
|
MISCELLANEOUS EXPENSES |
0.000 |
0.000 |
0.000 |
|
|
|
|
|
|
|
|
TOTAL |
3.146 |
2.236 |
1.593 |
|
PROFIT & LOSS
ACCOUNT
|
|
PARTICULARS |
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
|
|
|
|
|
|
|
|
|
|
Income |
15.066 |
12.829 |
8.878 |
|
|
|
Other Income |
|
|
|
|
|
|
TOTAL |
15.066 |
12.829 |
8.878 |
|
|
|
|
|
|
|
|
Less |
EXPENSES |
|
|
|
|
|
|
|
|
13.969 |
11.737 |
8.184 |
|
|
|
Administrative Expenses |
|
|
|
|
|
|
Advertising Expenses |
|
|
|
|
|
|
TOTAL |
13.969 |
11.737 |
8.184 |
|
|
|
|
|
|
|
|
|
PROFIT BEFORE
TAX |
1.097 |
1.092 |
0.694 |
|
|
|
|
|
|
|
|
|
Less |
TAX |
0.147 |
0.716 |
0.370 |
|
|
|
|
|
|
|
|
|
|
PROFIT AFTER TAX
|
0.950 |
0.376 |
0.324 |
|
|
|
|
|
|
|
|
|
Add |
PREVIOUS
YEARS’ BALANCE BROUGHT FORWARD |
1.272 |
0.896 |
0.572 |
|
|
|
|
|
|
|
|
|
|
BALANCE CARRIED
TO THE B/S |
2.222 |
1.272 |
0.896 |
|
|
|
|
|
|
|
|
|
|
EARNINGS IN
FOREIGN CURRENCY |
|
|
|
|
|
|
|
Export Earnings |
15.554 |
9.406 |
12.951 |
|
|
TOTAL EARNINGS |
15.554 |
9.406 |
12.951 |
|
|
|
|
|
|
|
|
|
|
Earnings Per
Share (Rs.) |
95.02 |
37.64 |
32.41 |
|
KEY RATIOS
|
PARTICULARS |
|
31.03.2010 |
31.03.2009 |
31.03.2008 |
|
PAT / Total Income |
(%) |
6.31
|
2.93 |
3.65 |
|
|
|
|
|
|
|
Return on Total Assets (PBT/Total Assets} |
(%) |
10.79
|
16.60 |
10.59 |
|
|
|
|
|
|
|
Return on Investment (ROI) (PBT/Networth) |
|
0.47
|
0.80 |
0.70 |
|
|
|
|
|
|
|
Debt Equity Ratio (Total Liability/Networth) |
|
3.50
|
3.83 |
5.62 |
|
|
|
|
|
|
|
Current Ratio (Current Asset/Current Liability) |
|
1.13
|
1.07 |
1.07 |
LOCAL AGENCY FURTHER INFORMATION
Note:
The registered office of the company has been shifted from 306, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block, Janak Puri, New Delhi – 110 058 to the present address w.e.f. 01.05.2011.
FORM 8:
|
Corporate
identity number of the company |
U74130DL1998PTC093006 |
|
Name of the
company |
BIOGENTEK BG ( |
|
Address of the registered
office or of the principal place of
business in |
306, Shahpuri Tirath Singh Tower, C-58, Community Centre, C Block,
Janak Puri, New Delhi – 110 058, India E-Mail: ravindra@biogentek.com |
|
This form is for |
Creation of
charge |
|
Type of charge |
Floating Charge |
|
Particular of
charge holder |
Corporation Bank, Janakpuri, E-Mail: 0522@corpbank.co.in |
|
Nature of
description of the instrument creating or modifying the charge |
Limit agreement
dated 28.12.2010 |
|
Date of
instrument Creating the charge |
28.12.2010 |
|
Amount secured by
the charge |
Rs.4.100 millions |
|
Brief particulars
of the principal terms an conditions and extent and operation of the charge |
Rate of Interest: Base Rate (8.25%)
+ 4.25 i.e. 12.5% p.a. at present subject to revision from time to time. The
bank reserves the right to revise the rate of interest based on gradation or
other reasons. Terms of
Repayment: OD-running
account repayable on demand subject to Annual renewal. Margin: Cash Margin 15% |
|
Short particulars
of the property charged |
Officer Premises
No. 8, IInd Floor, |
CONTINGENT
LIABILITY:
|
Particulars |
31.03.2010 (Rs.
in millions) |
|
Guarantees furnished by Bank remaining unexpired backed by personal
guarantee of Directors of the Company and against which Fixed Deposit of the
Company. Rs.1.497 millions are held as security. |
1.822 |
FIXED ASSETS:
v
Furniture and Fixture
v
Car
v
Computer
v
Office Equipments
v
Cycle
v
Scooter
WEBSITE DETAILS:
PROFILE:
Subject, one of
Ever since its inception, they at Subject, have truly been working with the philosophy of “Total Customer Satisfaction”, may it be by virtue of instrumentation supplied or the related after sales services rendered to their valued customers. For us, every user of ours has been a milestone achieved in their quest to excel in terms of support.
A dedicated team of their service personnel always in pursuit of excelling through their relentless efforts are available at the service at all times ,especially in situations, when the researcher or the production house is in need of some emergency assistance. It is noteworthy that such ready and timely support of ours is not just confined to the instrumentation / products supplied by us, but could also be extended to other makes as well.
Their association with their esteemed users over the years and their laudable and worthy suggestions henceforth have provided them with the all necessary momentum to keep ourselves continually upgraded and be associated with remarkably high quality product lines from all over the Europe and the United States.
Their users both from the research community as also from the production enterprises have further inspired them to develop certain innovative products within the country, which in due course will see their way through to the overseas markets as well.
Head quartered in
While the company with its enduring and sustained endeavors
would continue to enhance its impetus in the biotechnology business, due
emphasis to keep pace with the dynamically changing requirements of the
research and production community, especially the Biopharmaceutical World
(where India is readying itself to face the challenges of the Patent regime) in
the long term, emerges as the key anchor of their future growth
Their Vision is “to be one of the most avid and dependable associates in the
field of biotechnological and microbiological research and production".
CMT REPORT (Corruption, Money Laundering & Terrorism]
The Public Notice information has been collected from various sources
including but not limited to: The Courts,
1] INFORMATION ON
DESIGNATED PARTY
No exist designating subject or any of its beneficial owners,
controlling shareholders or senior officers as terrorist or terrorist
organization or whom notice had been received that all financial transactions
involving their assets have been blocked or convicted, found guilty or against
whom a judgement or order had been entered in a proceedings for violating
money-laundering, anti-corruption or bribery or international economic or
anti-terrorism sanction laws or whose assets were seized, blocked, frozen or
ordered forfeited for violation of money laundering or international
anti-terrorism laws.
2] Court Declaration :
No records exist to suggest that subject is
or was the subject of any formal or informal allegations, prosecutions or other
official proceeding for making any prohibited payments or other improper
payments to government officials for engaging in prohibited transactions or
with designated parties.
3] Asset Declaration :
No records exist to suggest that the property or assets of the subject
are derived from criminal conduct or a prohibited transaction.
4] Record on Financial
Crime :
Charges or conviction
registered against subject: None
5] Records on Violation of
Anti-Corruption Laws :
Charges or investigation
registered against subject: None
6] Records on Int’l
Anti-Money Laundering Laws/Standards :
Charges or
investigation registered against subject: None
7] Criminal Records
No available
information exist that suggest that subject or any of its principals have been
formally charged or convicted by a competent governmental authority for any
financial crime or under any formal investigation by a competent government
authority for any violation of anti-corruption laws or international anti-money
laundering laws or standard.
8] Affiliation with
Government :
No record
exists to suggest that any director or indirect owners, controlling
shareholders, director, officer or employee of the company is a government
official or a family member or close business associate of a Government
official.
9] Compensation Package :
Our market
survey revealed that the amount of compensation sought by the subject is fair
and reasonable and comparable to compensation paid to others for similar
services.
10] Press Report :
No press reports / filings exists on
the subject.
CORPORATE GOVERNANCE
MIRA INFORM as part of its Due Diligence do provide comments on Corporate
Governance to identify management and governance. These factors often have been
predictive and in some cases have created vulnerabilities to credit
deterioration.
Our Governance Assessment focuses principally on the interactions
between a company’s management, its Board of Directors, Shareholders and other
financial stakeholders.
CONTRAVENTION
Subject is not known to have contravened any existing local laws,
regulations or policies that prohibit, restrict or otherwise affect the terms
and conditions that could be included in the agreement with the subject.
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.44.42 |
|
|
1 |
Rs.72.49 |
|
Euro |
1 |
Rs.63.87 |
SCORE & RATING EXPLANATIONS
|
SCORE FACTORS |
RANGE |
POINTS |
|
HISTORY |
1~10 |
5 |
|
PAID-UP CAPITAL |
1~10 |
3 |
|
OPERATING SCALE |
1~10 |
4 |
|
FINANCIAL CONDITION |
|
|
|
--BUSINESS SCALE |
1~10 |
3 |
|
--PROFITABILIRY |
1~10 |
3 |
|
--LIQUIDITY |
1~10 |
4 |
|
--LEVERAGE |
1~10 |
3 |
|
--RESERVES |
1~10 |
3 |
|
--CREDIT LINES |
1~10 |
3 |
|
--MARGINS |
-5~5 |
- |
|
DEMERIT POINTS |
|
|
|
--BANK CHARGES |
YES/NO |
YES |
|
--LITIGATION |
YES/NO |
NO |
|
--OTHER ADVERSE INFORMATION |
YES/NO |
NO |
|
MERIT POINTS |
|
|
|
--SOLE DISTRIBUTORSHIP |
YES/NO |
NO |
|
--EXPORT ACTIVITIES |
YES/NO |
NO |
|
--AFFILIATION |
YES/NO |
NO |
|
--LISTED |
YES/NO |
NO |
|
--OTHER MERIT FACTORS |
YES/NO |
YES |
|
TOTAL |
|
31 |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
- |
NB |
New Business |
- |
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.